Valion Bio (VBIO) EBIT Margin (2021 - 2025)
Valion Bio (VBIO) posted EBIT Margin of -1700.68% for Q3 2025, down 564.97 percentage points from -1135.71% a year earlier but up 250.48 percentage points from the prior quarter.
Powered by 
Analysis
Valion Bio (VBIO) EBIT Margin (2021 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, EBIT Margin at Valion Bio was -1237.55%, down 566.50 percentage points year-over-year; for FY2024, it came in at -573.85%, up 127.26 percentage points from FY2023.
- Annual EBIT Margin shows a three-year change of -125.72 percentage points (FY2021 to FY2024).
- In prior years, Valion Bio's EBIT Margin was -701.11% in FY2023 (-152.30 pp), -548.80% in FY2022 (-100.67 pp) and -448.13% in FY2021.
- Quarterly EBIT Margin has run from a low of -2151.43% in Q1 2025 to a high of -165.56% in Q4 2024 over five years.
- On a year-over-year basis, EBIT Margin has declined in each of the last three quarters, with an average year-over-year change of -363.64 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2024, with a gain of 463.02 percentage points; the weakest was Q1 2025, with a drop of 1708.02 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -1951.16% (Q2 2025), -2151.43% (Q1 2025) and -165.56% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 32.98% |
| 10 | Valion Bio | 73,008.00 | -25.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,700.68% |
| Jun 30, 2025 | -1,951.16% |
| Mar 31, 2025 | -1,967.14% |
| Dec 31, 2024 | -165.56% |
| Sep 30, 2024 | -1,135.71% |
| Jun 30, 2024 | -904.29% |
| Mar 31, 2024 | -443.41% |
| Dec 31, 2023 | -628.57% |
| Sep 30, 2023 | -624.11% |
| Jun 30, 2023 | -1,319.88% |
| Mar 31, 2023 | -562.77% |
| Dec 31, 2022 | -552.94% |
| Sep 30, 2022 | -541.72% |
| Jun 30, 2022 | -571.59% |
| Mar 31, 2022 | -523.60% |
| Dec 31, 2021 | -589.20% |
| Sep 30, 2021 | -443.68% |
| Jun 30, 2021 | -393.66% |
| Mar 31, 2021 | -327.24% |
API Access
Valion Bio EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();